Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia

Pediatrics

Volumn 119, Issue 1, 2007, Pages

  Sabery, Nasim ^a   Bass, Dorsey ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ANCA; ASCA; Crohn disease; IBD; Pediatrics; Screening; Serologic testing; Ulcerative colitis

Indexed keywords

HEMOGLOBIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CERTIFICATION; CHILD; CLINICAL FEATURE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC PROCEDURE; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FALSE POSITIVE RESULT; FEMALE; HEALTH PRACTITIONER; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; NEWBORN; NEWBORN SCREENING; PEDIATRIC HOSPITAL; PREVALENCE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROLOGY; ULCERATIVE COLITIS; BLOOD; ISCHEMIC COLITIS; LABORATORY DIAGNOSIS; PREDICTION AND FORECASTING; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANEMIA; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; CHILD; CHILD, PRESCHOOL; COLITIS, ISCHEMIC; COLITIS, ULCERATIVE; CROHN DISEASE; FALSE POSITIVE REACTIONS; FEMALE; HEMOGLOBINS; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 33846897011     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1361     Document Type: Article

References (28)

1. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531
2. Bland RM, Evans TJ, Raine P, Weaver LT. Inflammatory bowel disease in Scottish children. Health Bull (Edinb). 1999;57:365-373
3. Kolek A, Janout V, Tichy M, Grepl M. The incidence of inflammatory bowel disease is increasing among children 15 years old and younger in the Czech Republic. J Pediatr Gastroenterol Nutr. 2004;38:362-363
4. Watson AJ, Johnston AT, Barker PM, Youngson GG, Bisset WM, Mahomed AA. The presentation and management of juvenile-onset chronic inflammatory bowel disease in Northeastern Scotland. J Pediatr Surg. 2002;37:83-86
5. Seidman EG. Recent advances in the diagnosis and treatment of pediatric inflammatory bowel disease. Curr Gastroenterol Rep. 2000;2:248-252
6. Heikenen JB, Werlin SL, Brown CW, Balint JP. Presenting symptoms and diagnostic lag in children with inflammatory bowel disease. Inflamm Bowel Dis. 1999;5:158-160
7. Moyer VA, Kennedy KA. Understanding and using diagnostic tests. Clin Perinatol. 2003;30:189-204
8. Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol. 2001;96:758-765
9. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004;99:2235-2241
10. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426-431
11. Khan K, Schwarzenberg SJ, Sharp H, Greenwood D, Weisdorf-Schindele S. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:325-329
12. Shine B, Berghouse L, Jones JE, Landon J. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta. 1985;148:105-109
13. Beattie RM, Walker-Smith JA, Murch SH. Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child. 1995;73:354-355
14. Canani RB, Romano MT, Greco L, et al. Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease. Inflamm Bowel Dis. 2004;10:234-239
15. Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child. 2004;89:69-71
16. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115:822-829
17. Kim JE, Kim KS, Seo JK. Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease [in Korean]. Korean J Gastroenterol. 2003;42:297-302
18. Elitsur Y, Lawrence Z, Tolaymat N. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience. J Clin Gastroenterol. 2005;39:6703
19. Abreu MT. Controversies in IBD. Serologic tests are helpful in managing inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:222-226, 230-231
20. Present DH. Serologic tests are not helpful in managing inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:227-229; discussion 223, 230-231
21. Vernier G, Sendid B, Poulain D, Colombel JF. Relevance of serologic studies in inflammatory bowel disease. Curr Gastroenterol Rep. 2004;6:482-487
22. Gupta SK, Fitzgerald JF, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Inflamm Bowel Dis. 2004;10:240-244
23. Canani RB, de Horatio LT, Terrin G, et al. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2006;42:9-15
24. Dubinsky MC, Johanson JF, Seidman EG, Ofman JJ. Suspected inflammatory bowel disease-the clinical and economic impact of competing diagnostic strategies. Am J Gastroenterol. 2002;97:2333-2342
25. Damoiseaux JG, Bouten B, Linders AM, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol. 2002;22:281-288
26. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr. 1999;134:447-452
27. Olives JP, Breton A, Hugot JP, et al. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value. J Pediatr Gastroenterol Nutr. 1997;25:142-148
28. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1-7